NEW DELHI , APRIL 29 : The National Technical Advisory Group on Immunization (NTAGI) on Friday approved Serum Institute of India’s Covid-19 vaccine Covovax for the 12-17 age group. The government panel decided to include Covovax in India’s immunisation drive against Covid-19. This makes Covovax another option for vaccines for children between the ages of […]Continue Reading
